Page last updated: 2024-10-26

etodolac and Joint Diseases

etodolac has been researched along with Joint Diseases in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Joint Diseases: Diseases involving the JOINTS.

Research Excerpts

ExcerptRelevanceReference
"The goal of this study was to look for correlations between the severity of chronic inflammatory joint disease and pharmacokinetic parameters of nonsteroidal antiinflammatory drugs."2.68Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac. ( Goasguen, J; Guggenbuhl, P; Jacquelinet, C; Lapicque, F; Le Dantec, P; Netter, P; Pawlotsky, Y; Perdriger, A; Veillard, E, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pawlotsky, Y1
Le Dantec, P1
Jacquelinet, C1
Lapicque, F1
Goasguen, J1
Perdriger, A1
Veillard, E1
Guggenbuhl, P1
Netter, P1

Trials

1 trial available for etodolac and Joint Diseases

ArticleYear
Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
    Revue du rhumatisme (English ed.), 1996, Volume: 63, Issue:3

    Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Ar

1996